TSE:HSM Helius Medical Technologies (HSM) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free HSM Stock Alerts C$18.35 -0.32 (-1.71%) (As of 09/9/2021) Add Compare Share Share Today's RangeC$18.35▼C$18.4850-Day RangeC$18.35▼C$18.3552-Week RangeC$14.26▼C$40.00Volume930 shsAverage Volume3,578 shsMarket CapitalizationC$42.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Helius Medical Technologies alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Helius Medical TechnologiesHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.Read More HSM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSM Stock News HeadlinesApril 17, 2024 | msn.comHelius Medical Technologies (HSDT) Price Target Decreased by 9.73% to 15.78April 1, 2024 | msn.comHelius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial ChallengesApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 28, 2024 | benzinga.comRecap: Helius Medical Tech Q4 EarningsFebruary 10, 2024 | msn.comHelius Medical Technologies Boosts Finance with Stock SalesNovember 1, 2023 | morningstar.comHelius Medical Technologies Inc Class A HSDTAugust 10, 2023 | msn.comHelius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06MMay 11, 2023 | msn.comHelius Medical Tech: Q1 Earnings InsightsApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.May 10, 2023 | msn.comEarnings Outlook For Helius Medical TechApril 13, 2023 | benzinga.comHelius Medical Tech Stock (NASDAQ:HSDT), Guidance and ForecastMarch 14, 2023 | msn.comHelius Medical Tech's Return On Capital Employed InsightsJanuary 23, 2023 | yahoo.comHelius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022December 23, 2022 | msn.comLooking Into Helius Medical Tech's Return On Capital EmployedNovember 18, 2022 | msn.comHelius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the UpgradeOctober 25, 2022 | forbes.comHelius Medical TechnologiesMay 4, 2022 | nz.finance.yahoo.comEmerging Markets Report: The Air We ShareMay 4, 2022 | yahoo.comSpotify becomes first music streamer to launch on RobloxMay 4, 2022 | financialpost.comGlobenewswire | Financial PostApril 26, 2022 | marketwatch.comHelius Medical Shares Up After U.S. Introduction of Multiple Sclerosis DeviceAugust 18, 2021 | finance.yahoo.comWe're Keeping An Eye On Helius Medical Technologies' (NASDAQ:HSDT) Cash Burn RateAugust 12, 2021 | finance.yahoo.comHelius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)See More Headlines Receive HSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolTSE:HSM CUSIPN/A CIKN/A Webheliusmedical.com Phone215-944-6100FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio152.92 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.74 Current Ratio4.20 Quick Ratio3.58 Sales & Book Value Annual SalesC$477,000.00 Price / Sales89.17 Cash FlowC$3.21 per share Price / Cash Flow5.71 Book ValueC$3.61 per share Price / Book5.08Miscellaneous Outstanding Shares2,318,000Free FloatN/AMarket CapC$42.54 million OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Dane Carl Andreeff (Age 55)Pres, CEO & Director Comp: $2.5kMr. Jeffrey S. Mathiesen CPA (Age 60)CPA, CFO & Treasurer Comp: $5kMs. Joyce N. LaViscount (Age 59)COO & Sec. Comp: $388.3kDr. Jonathan Mark Sackier (Age 63)Consultant Comp: $201.65kMr. Frederick FantazziaVP of Sales & Marketing- North AmericaDr. Brian W. Bapty Ph.D. (Age 52)VP of Strategy and Bus. Devel. Mr. Mark LenoVP & GM of Canadian OperationsMore ExecutivesKey CompetitorsTheralase TechnologiesCVE:TLTProtech Home MedicalCVE:PHMVentriPoint DiagnosticsCVE:VPTMedX HealthCVE:MDXAurora SpineCVE:ASGView All Competitors HSM Stock Analysis - Frequently Asked Questions How have HSM shares performed in 2024? Helius Medical Technologies' stock was trading at C$18.35 at the beginning of the year. Since then, HSM shares have increased by 0.0% and is now trading at C$18.35. View the best growth stocks for 2024 here. What other stocks do shareholders of Helius Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Helius Medical Technologies investors own include VanEck Junior Gold Miners ETF (GDXJ), Sleep Country Canada (ZZZ), Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB) and Air Canada (AC). How do I buy shares of Helius Medical Technologies? Shares of HSM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:HSM) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
